MARKET WIRE NEWS
  1. Home
  2. Stock
  3. COCP
  4. News
COCP
Quote
Short
News
Articles
Message Board

Cocrystal Pharma Inc. (NASDAQ : COCP ) News

Cocrystal Pharma Inc. (NASDAQ: COCP) News Releases

COCP News Releases
COCP : NASDAQ
GlobeNewswire
Cocrystal Pharma's First Oral Norovirus Protease Inhibitor CDI-988 to be Featured at the International Society for Antiviral Research Conference (ICAR) 2026
COCP : NASDAQ
GlobeNewswire
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
COCP : NASDAQ
SeekingAlpha
Cocrystal Pharma GAAP EPS of -$0.19 beats by $0.02
COCP : NASDAQ
GlobeNewswire
Cocrystal Pharma Reports Third Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
COCP : NASDAQ
US Earnings Reports
Expected US Company Earnings on Wednesday, November 12th, 2025
COCP : NASDAQ
GlobeNewswire
Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules
COCP : NASDAQ
GlobeNewswire
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
COCP : NASDAQ
SeekingAlpha
Cocrystal Pharma files to sell 5.74M shares of common stock for holders
COCP : NASDAQ
GlobeNewswire
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
COCP : NASDAQ
PRISM News
Cocrystal Pharma Showcases CDI-988, a First-in-Class Oral Antiviral for Norovirus

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.